High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
TSThe Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
Délégation Paris 7 · Université Paris Cité
Indexed incrossrefpubmed
Abstract
Background
Statins reduce the incidence of strokes among patients at increased risk for cardiovascular disease; whether they reduce the risk of stroke after a recent stroke or transient ischemic attack (TIA) remains to be established.
Methods
We randomly assigned 4731 patients who had had a stroke or TIA within one to six months before study entry, had low-density lipoprotein (LDL) cholesterol levels of 100 to 190 mg per deciliter (2.6 to 4.9 mmol per liter), and had no known coronary heart disease to double-blind treatment with 80 mg of atorvastatin per day or placebo. The primary end point was a first nonfatal or fatal stroke.
Citation impact
2,881
total citations
- FWCI
- 180.56
- Percentile
- 100%
- References
- 21
Citations per year
Authors
1- TSThe Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) InvestigatorsCorresponding
Délégation Paris 7, Université Paris Cité
Topics & keywords
Topics
Keywords
- Medicine
- Atorvastatin
- Hazard ratio
- Stroke (engine)
- Placebo
- Confidence interval
- Internal medicine
- Liter
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.